Lexaria Bioscience Corp.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2015 | -103.3% | -13,489.8% | -13,489.8% |
| FY2016 | -12.0% | -3,136.8% | -3,136.8% |
| FY2017 | 53.3% | -3,028.7% | -3,031.9% |
| FY2018 | 94.2% | -1,525.4% | -1,525.4% |
| FY2019 | 89.7% | -1,868.0% | -1,868.0% |
| FY2020 | 68.4% | -1,266.6% | -1,297.6% |
| FY2021 | 75.7% | -786.8% | -557.2% |
| FY2022 | 71.9% | -2,591.7% | -2,846.3% |
| FY2023 | 86.1% | -2,888.5% | -2,946.4% |
| FY2024 | 99.0% | -1,239.2% | -1,248.2% |